Light blocking container with content viewing window and contrast background

Abstract

Several embodiments of the invention provide a container ( 10 ) for housing a composition comprising at least one active pharmaceutical agent, the container including an interior ( 60 ) for housing the composition and a viewing window ( 30 ) allowing the user to view the interior region from the outside of the container. In some embodiments, the container is a multi-layered wall. In other aspects, the container ( 200 ) includes a main body portion ( 210 ) and a base portion ( 230 ), the base portion having a tapered bottom ( 235 ), and the main body portion having a viewing window ( 220 ) to allow viewing of the interior of the container from the outside thereof.

1 . A container for housing a composition comprising at least one active pharmaceutical agent, the container comprising:
 a. an interior for housing the composition comprising at least one active pharmaceutical agent;   b. a container wall having an inner surface and an outer surface, wherein the inner surface is in communication with the interior; and   c. a viewing window extending through the container wall so as to permit viewing of the interior from the outside of the container;   wherein the container wall includes a colorant so as to define a background in the interior, the background defining a contrasting backdrop to the composition when viewed through the viewing window.   
     
     
         2 . The container of  claim 1 , wherein the container comprises a plastic material. 
     
     
         3 . The container of  claim 1 , wherein the container wall is opaque. 
     
     
         4 . The container of  claim 1 , wherein the colorant is dark-colored. 
     
     
         5 . The container of  claim 1 , wherein the colorant is an opacifier. 
     
     
         6 . The container of  claim 1 , further comprising a UV protectant material. 
     
     
         7 . The container of  claim 1 , comprising a spraying mechanism attached to the container and providing access to the interior. 
     
     
         8 . The container of  claim 1 , wherein the container wall comprises a first layer forming the inner surface and a second layer forming the second surface. 
     
     
         9 . The container of  claim 8 , wherein the second layer comprises the colorant. 
     
     
         10 . The container of  claim 8 , further comprising a third layer, the third layer applied to an outer surface of the second layer. 
     
     
         11 . The container of  claim 1 , wherein the viewing window is substantially free of colorant. 
     
     
         12 . The container of  claim 1 , wherein the outer surface comprises titanium. 
     
     
         13 . The container of  claim 1 , wherein the outer surface comprises at least one material selected from the group consisting of high density polyethylene, polypropylene, polyester, cyclic olefin copolymer and combinations thereof. 
     
     
         14 . The container of  claim 1 , wherein the inner surface comprises a material selected from the group consisting of high density polyethylene, polypropylene, polyester, cyclic olefin copolymer and combinations thereof. 
     
     
         15 . The container of  claim 1 , wherein the window comprises a material selected from the group consisting of polypropylene, cyclic olefin copolymer and combinations thereof. 
     
     
         16 . The container of  claim 1 , wherein the window is a cyclic olefin copolymer. 
     
     
         17 . A container for housing a composition comprising at least one active pharmaceutical agent, the container comprising:
 a. an interior region, which comprises:
 i. a main body portion; and 
 ii. a bottom portion having a tapered interior surface; and 
   b. a viewing window extending from the bottom of the main body portion to the top of the main body portion, allowing a user to view the interior region   wherein the main body portion includes a colorant so as to define a background in the interior region, the background defining a contrasting backdrop to the composition when viewed through the viewing window.   
     
     
         18 . The container of  claim 17 , comprising a spraying mechanism attached to the container and providing access to the interior. 
     
     
         19 . A drug product comprising:
 a. a composition comprising at least one active pharmaceutical agent;   b. an interior for housing the composition;   c. a container wall having an inner surface and an outer surface, wherein the inner surface is in communication with the interior; and   d. a viewing window extending through the container wall so as to permit viewing of the interior from the outside of the container;   wherein the container wall includes a colorant so as to define a background in the interior, the background defining a contrasting backdrop to the composition when viewed through the viewing window.   
     
     
         20 . The drug product of  claim 19 , wherein the composition is a light or clear liquid. 
     
     
         21 . The drug product of  claim 19 , wherein the composition comprises at least one photosensitive active pharmaceutical agent. 
     
     
         22 . The drug product of  claim 19 , wherein the at least one photosensitive active pharmaceutical agent is selected from the group consisting of mometasone furoate monohydrate, oxymetazoline, azelastine, fluticasone furoate, fluticasone propionate and combinations thereof.